Abstract
Shigella and enteroinvasive Escherichia coli (EIEC) are gram-negative bacteria responsible for bacillary dysentery (shigellosis) in humans, which is characterized by invasion and inflammatory destruction of the human colonic epithelium. Different EIEC and Shigella subgroups rose independently from commensal E. coli through patho-adaptive evolution that included loss of functional genes interfering with the virulence and/or with the intracellular lifestyle of the bacteria, as well as acquisition of genetic elements harboring virulence genes. Among the latter is the large virulence plasmid encoding for a type three secretion system (T3SS), which enables translocation of virulence proteins (effectors) from the bacterium directly into the host cell cytoplasm. These effectors enable the pathogen to subvert epithelial cell functions, promoting its own uptake, replication in the host cytosol, and dissemination to adjacent cells while concomitantly inhibiting pro-inflammatory cell death. Furthermore, T3SS effectors are directly involved in Shigella manipulation of immune cells causing their dysfunction and promoting cell death. In the current chapter, we first describe the evolution of the enteroinvasive pathovars and then summarize the overall knowledge concerning the pathogenesis of these bacteria, with a particular focus on Shigella flexneri. Subversion of host cell functions in the human gut, both epithelial and immune cells, by different virulence factors is especially highlighted.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal P, Uppal B, Ghosh R et al (2016) Multi drug resistance and extended spectrum beta lactamases in clinical isolates of Shigella: a study from New Delhi, India. Travel Med Infect Dis 14:407–413. https://doi.org/10.1016/j.tmaid.2016.05.006
Al-Hasani K, Navarro-Garcia F, Huerta J et al (2009) The immunogenic SigA enterotoxin of S. flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells. PLoS ONE 4:e8223. https://doi.org/10.1371/journal.pone.0008223
Anderson M, Sansonetti PJ, Marteyn BS (2016) Shigella diversity and changing landscape: insights for the twenty-first century. Front Cell Infect Microbiol 6:45. https://doi.org/10.3389/fcimb.2016.00045
Arizmendi O, Picking WD, Picking WL (2016) Macrophage apoptosis triggered by IpaD from S. flexneri. Infect Immun 84:1857–1865. https://doi.org/10.1128/IAI.01483-15
Ashida H, Mimuro H, Sasakawa C (2015) Shigella manipulates host immune responses by delivering effector proteins with specific roles. Front Immunol 6:219. https://doi.org/10.3389/fimmu.2015.00219
Barman S, Saha DR, Ramamurthy T, Koley H (2011) Development of a new guinea-pig model of shigellosis. FEMS Immunol Med Microbiol 62:304–314. https://doi.org/10.1111/j.1574-695X.2011.00810.x
Barzu S, Benjelloun-Touimi Z, Phalipon A et al (1997) Functional analysis of the S. flexneri IpaC invasin by insertional mutagenesis. Infect Immun 65:1599–1605
Becker SL, Chatigre JK, Gohou J-P et al (2015) Combined stool-based multiplex PCR and microscopy for enhanced pathogen detection in patients with persistent diarrhoea and asymptomatic controls from Côte d’Ivoire. Clin Microbiol Infect 21(591):e1–e10. https://doi.org/10.1016/j.cmi.2015.02.016
Bensted HJ (1956) Dysentery bacilli-Shigella; a brief historical review. Can J Microbiol 2:163–174
Bergounioux J, Elisee R, Prunier A-L et al (2012) Calpain activation by the S. flexneri effector VirA regulates key steps in the formation and life of the bacterium’s epithelial niche. Cell Host Microbe 11:240–252. https://doi.org/10.1016/j.chom.2012.01.013
Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7:99–109. https://doi.org/10.1038/nrmicro2070
Bhattacharya D, Bhattacharya H, Sayi DS et al (2015) Changing patterns and widening of antibiotic resistance in Shigella spp. over a decade (2000–2011), Andaman Islands. India. Epidemiol Infect 143:470–477. https://doi.org/10.1017/S0950268814000958
Bhattacharya D, Bhattacharya H, Thamizhmani R et al (2014) Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis 33:157–170. https://doi.org/10.1007/s10096-013-1937-2
Blocker A, Gounon P, Larquet E et al (1999) The tripartite type III secreton of S. flexneri inserts IpaB and IpaC into host membranes. J Cell Biol 147:683–693
Bougneres L, Girardin SE, Weed SA et al (2004) Cortactin and Crk cooperate to trigger actin polymerization during Shigella invasion of epithelial cells. J Cell Biol 166:225–235
Bourdet-Sicard R, Rüdiger M, Jockusch BM et al (1999) Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. EMBO J 18:5853–5862. https://doi.org/10.1093/emboj/18.21.5853
Bravo V, Puhar A, Sansonetti P et al (2015) Distinct mutations led to inactivation of type 1 fimbriae expression in Shigella spp. PLoS ONE 10:e0121785
Brinkmann V, Reichard U, Goosmann C et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535
Brotcke Zumsteg A, Goosmann C, Brinkmann V et al (2014) IcsA is a S. flexneri adhesin regulated by the type III secretion system and required for pathogenesis. Cell Host Microbe 15:435–445. https://doi.org/10.1016/j.chom.2014.03.001
Buchrieser C, Glaser P, Rusniok C et al (2000) The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of S. flexneri. Mol Microbiol 38:760–771
Burnaevskiy N, Fox TG, Plymire DA et al (2013) Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 496:106–109. https://doi.org/10.1038/nature12004
Burnaevskiy N, Peng T, Reddick LE et al (2015) Myristoylome profiling reveals a concerted mechanism of ARF GTPase deacylation by the bacterial protease IpaJ. Mol Cell 58:110–122. https://doi.org/10.1016/j.molcel.2015.01.040
Caboni M, Pedron T, Rossi O et al (2015) An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei. PLoS Pathog 11:e1004749
Calcuttawala F, Hariharan C, Pazhani GP et al (2015) Activity spectrum of colicins produced by Shigella sonnei and genetic mechanism of colicin resistance in conspecific S. sonnei strains and E. coli. Antimicrob Agents Chemother 59:152–158. https://doi.org/10.1128/AAC.04122-14
Campbell-Valois F-X, Sachse M, Sansonetti PJ, Parsot C (2015) Escape of Actively Secreting S. flexneri from ATG8/LC3-positive vacuoles formed during cell-to-cell spread is facilitated by IcsB and VirA. MBio 6:e02567–14. https://doi.org/10.1128/mBio.02567-14
Campbell-Valois F-X, Schnupf P, Nigro G et al (2014) A fluorescent reporter reveals on/off regulation of the Shigella type III secretion apparatus during entry and cell-to-cell spread. Cell Host Microbe 15:177–189. https://doi.org/10.1016/j.chom.2014.01.005
Carayol N, Tran van Nhieu G (2013) Tips and tricks about Shigella invasion of epithelial cells. Curr Opin Microbiol 16:32–37. https://doi.org/10.1016/j.mib.2012.11.010
Casalino M, Latella MC, Prosseda G, Colonna B (2003) CadC is the preferential target of a convergent evolution driving enteroinvasive E. coli toward a lysine decarboxylase-defective phenotype. Infect Immun 71:5472–5479
Casalino M, Latella MC, Prosseda G et al (2005) Molecular evolution of the lysine decarboxylase-defective phenotype in Shigella sonnei. Int J Med Microbiol 294:503–512
Cohen D, Block C, Green MS et al (1989) Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. J Clin Microbiol 27:162–167
Cui X, Yang C, Wang J et al (2015) Antimicrobial resistance of S. flexneri Serotype 1b Isolates in China. PLoS ONE 10:e0129009. https://doi.org/10.1371/journal.pone.0129009
Day CJ, Tran EN, Semchenko EA et al (2015) Glycan:glycan interactions: high affinity biomolecular interactions that can mediate binding of pathogenic bacteria to host cells. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.1421082112
Day WAJ, Fernandez RE, Maurelli AT (2001) Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp. Infect Immun 69:7471–7480. https://doi.org/10.1128/IAI.69.12.7471-7480.2001
Dickenson NE, Zhang L, Epler CR et al (2011) Conformational changes in IpaD from S. flexneri upon binding bile salts provide insight into the second step of type III secretion. Biochemistry 50:172–180. https://doi.org/10.1021/bi101365f
Dong N, Zhu Y, Lu Q et al (2012) Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses. Cell 150:1029–1041. https://doi.org/10.1016/j.cell.2012.06.050
Doyle M (1989) foodborne bacterial pathogens. CRC Press
DuPont HL, Levine MM, Hornick RB, Formal SB (1989) Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 159:1126–1128
Durand JM, Dagberg B, Uhlin BE, Bjork GR (2000) Transfer RNA modification, temperature and DNA superhelicity have a common target in the regulatory network of the virulence of S. flexneri: the expression of the virF gene. Mol Microbiol 35:924–935
Edgeworth JD, Spencer J, Phalipon A et al (2002) Cytotoxicity and interleukin-1beta processing following S. flexneri infection of human monocyte-derived dendritic cells. Eur J Immunol 32:1464–1471. https://doi.org/10.1002/1521-4141(200205)32:5%3c1464:AID-IMMU1464%3e3.0.CO;2-G
Edwards PR, Ewing WH (1986) Edwards and Ewing’s identification of enterobacteriaceae. Elsevier Publishing Company
Egile C, Loisel TP, Laurent V et al (1999) Activation of the CDC42 effector N-WASP by the S. flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility. J Cell Biol 146:1319–1332
Epler CR, Dickenson NE, Olive AJ et al (2009) Liposomes recruit IpaC to the S. flexneri type III secretion apparatus needle as a final step in secretion induction. Infect Immun 77:2754–2761. https://doi.org/10.1128/IAI.00190-09
Ewing WH (1949) The relationship of shigella dispar to certain coliform bacteria. J Bacteriol 58:497–500
Faherty CS, Redman JC, Rasko DA et al (2012) S. flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure. Mol Microbiol 85:107–121. https://doi.org/10.1111/j.1365-2958.2012.08092.x
Farfan MJ, Toro CS, Barry EM, Nataro JP (2011) Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells. FEMS Immunol Med Microbiol 61:332–339. https://doi.org/10.1111/j.1574-695X.2011.00778.x
Farmer JJ, Davis BR (1985) H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting E. coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 22:620–625
Fasano A, Noriega FR, Maneval DRJ et al (1995) Shigella enterotoxin 1: an enterotoxin of S. flexneri 2a active in rabbit small intestine in vivo and in vitro. J Clin Invest 95:2853–2861. https://doi.org/10.1172/JCI117991
François M, Le Cabec V, Dupont MA et al (2000) Induction of necrosis in human neutrophils by S. flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization. Infect Immun 68:1289–1296
Franzon VL, Arondel J, Sansonetti PJ (1990) Contribution of superoxide dismutase and catalase activities to S. flexneri pathogenesis. Infect Immun 58:529–535
Fukumatsu M, Ogawa M, Arakawa S et al (2012) Shigella targets epithelial tricellular junctions and uses a noncanonical clathrin-dependent endocytic pathway to spread between cells. Cell Host Microbe 11:325–336. https://doi.org/10.1016/j.chom.2012.03.001
GBD 2013 DALYS and HALE Collaborators, Murray CJL, Barber RM, et al (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386:2145–2191. https://doi.org/10.1016/s0140-6736(15)61340-x
GBD (2013b) Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171. https://doi.org/10.1016/S0140-6736(14)61682-2
Gorden J, Small PL (1993) Acid resistance in enteric bacteria. Infect Immun 61:364–367
Guerrero L, Calva JJ, Morrow AL et al (1994) Asymptomatic Shigella infections in a cohort of Mexican children younger than two years of age. Pediatr Infect Dis J 13:597–602
Haider K, Hossain A, Wanke C et al (1993) Production of mucinase and neuraminidase and binding of Shigella to intestinal mucin. J Diarrhoeal Dis Res 11:88–92
Hancock RE, Diamond G (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8:402–410
Harrington A, Darboe N, Kenjale R et al (2006) Characterization of the interaction of single tryptophan containing mutants of IpaC from S. flexneri with phospholipid membranes. Biochemistry 45:626–636. https://doi.org/10.1021/bi0512593
Henderson IR, Czeczulin J, Eslava C et al (1999) Characterization of pic, a secreted protease of S. flexneri and enteroaggregative E. coli. Infect Immun 67:5587–5596
High N, Mounier J, Prevost MC, Sansonetti PJ (1992) IpaB of S. flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J 11:1991–1999
Hong M, Payne SM (1997) Effect of mutations in S. flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol Microbiol 24:779–791
Hoshino K, Takeuchi O, Kawai T et al (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749–3752
Hume PJ, McGhie EJ, Hayward RD, Koronakis V (2003) The purified Shigella IpaB and Salmonella SipB translocators share biochemical properties and membrane topology. Mol Microbiol 49:425–439
Ingersoll MA, Moss JE, Weinrauch Y et al (2003) The ShiA protein encoded by the S. flexneri SHI-2 pathogenicity island attenuates inflammation. Cell Microbiol 5:797–807
Islam D, Bandholtz L, Nilsson J et al (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180–185. https://doi.org/10.1038/84627
Islam D, Bardhan PK, Lindberg AA, Christensson B (1995a) Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease. Infect Immun 63:2941–2949
Islam D, Wretlind B, Ryd M et al (1995b) Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis. Infect Immun 63:2054–2061
Ito H, Kido N, Arakawa Y et al (1991) Possible mechanisms underlying the slow lactose fermentation phenotype in Shigella spp. Appl Environ Microbiol 57:2912–2917
Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291–295. https://doi.org/10.1126/science.1183021
Izhar M, Nuchamowitz Y, Mirelman D (1982) Adherence of S. flexneri to guinea pig intestinal cells is mediated by a mucosal adhesion. Infect Immun 35:1110–1118
Janeway CA, Murphy K, Travers P, Walport M (2009) Immunobiologie. De Boeck Supérieur
Jin Q, Yuan Z, Xu J et al (2002) Genome sequence of S. flexneri 2a: insights into pathogenicity through comparison with genomes of E. coli K12 and O157. Nucleic Acids Res 30:4432–4441
Khaghani S, Shamsizadeh A, Nikfar R, Hesami A (2014) S. flexneri: a three-year antimicrobial resistance monitoring of isolates in a Children Hospital, Ahvaz. Iran. Iran J Microbiol 6:225–229
Killackey SA, Sorbara MT, Girardin SE (2016) Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes. Front Cell Infect Microbiol 6:38. https://doi.org/10.3389/fcimb.2016.00038
Kim HJ, Li H, Collins JJ, Ingber DE (2016) Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A 113:E7–E15. https://doi.org/10.1073/pnas.1522193112
Kim M, Ogawa M, Fujita Y et al (2009) Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature 459:578–582. https://doi.org/10.1038/nature07952
Kobayashi T, Ogawa M, Sanada T et al (2013) The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe 13:570–583. https://doi.org/10.1016/j.chom.2013.04.012
Konradt C, Frigimelica E, Nothelfer K et al (2011) The S. flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism. Cell Host Microbe 9:263–272. https://doi.org/10.1016/j.chom.2011.03.010
Kotloff KL, Nataro JP, Blackwelder WC et al (2013) Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209–222. https://doi.org/10.1016/S0140-6736(13)60844-2
Kuehl CJ, Dragoi A-M, Agaisse H (2014) The S. flexneri type 3 secretion system is required for tyrosine kinase-dependent protrusion resolution, and vacuole escape during bacterial dissemination. PLoS ONE 9:e112738. https://doi.org/10.1371/journal.pone.0112738
Kueltzo LA, Osiecki J, Barker J et al (2003) Structure-function analysis of invasion plasmid antigen C (IpaC) from S. flexneri. J Biol Chem 278:2792–2798
Lafont F, Tran van Nhieu G, Hanada K et al (2002) Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J 21:4449–4457
Lamberti LM, Bourgeois AL, Fischer-Walker CL et al (2014) Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic E. coli among older children, adolescents, and adults in South Asia and Africa. PLoS Negl Trop Dis 8:e2705. https://doi.org/10.1371/journal.pntd.0002705
Lan R, Alles MC, Donohoe K et al (2004) Molecular evolutionary relationships of enteroinvasive E. coli and Shigella spp. Infect Immun 72:5080–5088
Lanata CF, Fischer-Walker CL, Olascoaga AC et al (2013) Global causes of diarrheal disease mortality in children. PLoS ONE 8:e72788. https://doi.org/10.1371/journal.pone.0072788
Levine MM, Kotloff KL, Barry EM et al (2007) Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 5:540–553. https://doi.org/10.1038/nrmicro1662
Lingwood CA (2003) Shiga toxin receptor glycolipid binding. Pathology Utility. Methods Mol Med 73:165–186
Luster AD (2002) The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 14:129–135
Mani S, Wierzba T, Walker RI (2016) Status of vaccine research and development for Shigella. Vaccine 34:2887–2894. https://doi.org/10.1016/j.vaccine.2016.02.075
Marteyn B, West NP, Browning DF et al (2010) Modulation of Shigella virulence in response to available oxygen in vivo. Nature 465:355–358. https://doi.org/10.1038/nature08970
Martins dos Santos V, Muller M, de Vos WM (2010) Systems biology of the gut: the interplay of food, microbiota and host at the mucosal interface. Curr Opin Biotechnol 21:539–550. https://doi.org/10.1016/j.copbio.2010.08.003
Maurelli AT, Fernandez RE, Bloch CA et al (1998) “Black holes” and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive E. coli. Proc Natl Acad Sci U S A 95:3943–3948
Maurelli AT, Sansonetti PJ (1988) Identification of a chromosomal gene controlling temperature-regulated expression of Shigella virulence. Proc Natl Acad Sci U S A 85:2820–2824
McCord JM, Fridovich I (1978) The biology and pathology of oxygen radicals. Ann Intern Med 89:122–127
Mellouk N, Weiner A, Aulner N et al (2014) Shigella subverts the host recycling compartment to rupture its vacuole. Cell Host Microbe 16:517–530. https://doi.org/10.1016/j.chom.2014.09.005
Mostowy S, Bonazzi M, Hamon MA et al (2010) Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe 8:433–444. https://doi.org/10.1016/j.chom.2010.10.009
Mounier J, Boncompain G, Senerovic L et al (2012) Shigella effector IpaB-induced cholesterol relocation disrupts the Golgi complex and recycling network to inhibit host cell secretion. Cell Host Microbe 12:381–389. https://doi.org/10.1016/j.chom.2012.07.010
Mounier J, Vasselon T, Hellio R et al (1992) S. flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infect Immun 60:237–248
Murray CJL, Vos T, Lozano R et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2197–2223. https://doi.org/10.1016/S0140-6736(12)61689-4
Nataro JP, Seriwatana J, Fasano A et al (1995) Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive E. coli and Shigella strains. Infect Immun 63:4721–4728
Niebuhr K, Jouihri N, Allaoui A et al (2000) IpgD, a protein secreted by the type III secretion machinery of S. flexneri, is chaperoned by IpgE and implicated in entry focus formation. Mol Microbiol 38:8–19
Nothelfer K, Arena ET, Pinaud L et al (2014) B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection. J Exp Med 211:1215–1229. https://doi.org/10.1084/jem.20130914
Ogawa M, Handa Y, Ashida H et al (2008) The versatility of Shigella effectors. Nat Rev Microbiol 6:11–16. https://doi.org/10.1038/nrmicro1814
Ogawa M, Yoshimori T, Suzuki T et al (2005) Escape of intracellular Shigella from autophagy. Science 307:727–731. https://doi.org/10.1126/science.1106036
Paciello I, Silipo A, Lembo-Fazio L et al (2013) Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation. Proc Natl Acad Sci U S A 110:E4345–E4354. https://doi.org/10.1073/pnas.1303641110
Parsot C (2009) Shigella type III secretion effectors: how, where, when, for what purposes? Curr Opin Microbiol 12:110–116. https://doi.org/10.1016/j.mib.2008.12.002
Parsot C (2005) Shigella spp. and enteroinvasive E. coli pathogenicity factors. FEMS Microbiol Lett 252:11–18. https://doi.org/10.1016/j.femsle.2005.08.046
Patel SK, Dotson J, Allen KP, Fleckenstein JM (2004) Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic E. coli. Infect Immun 72:1786–1794
Payne SM, Wyckoff EE, Murphy ER et al (2006) Iron and pathogenesis of Shigella: iron acquisition in the intracellular environment. Biometals 19:173–180. https://doi.org/10.1007/s10534-005-4577-x
Pendaries C, Tronchere H, Arbibe L et al (2006) PtdIns5P activates the host cell PI3-kinase/Akt pathway during S. flexneri infection. EMBO J 25:1024–1034. https://doi.org/10.1038/sj.emboj.7601001
Pettengill EA, Pettengill JB, Binet R (2015) Phylogenetic analyses of Shigella and Enteroinvasive E. coli for the identification of markers: whole-genome comparative analysis does not support distinct genera designation. Front Microbiol 6:1573. https://doi.org/10.3389/fmicb.2015.01573
Phalipon A, Kaufmann M, Michetti P et al (1995) Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of S. flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med 182:769–778
Phalipon A, Sansonetti PJ (2007) Shigella’s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 85:119–129. https://doi.org/10.1038/sj.icb7100025
Poltorak A, He X, Smirnova I et al (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088
Poramathikul K, Bodhidatta L, Chiek S et al (2016) Multidrug-Resistant Shigella infections in patients with diarrhea, Cambodia, 2014-2015. Emerg Infect Dis 22:1640–1643. https://doi.org/10.3201/eid2209.152058
Porter ME, Dorman CJ (1994) A role for H-NS in the thermo-osmotic regulation of virulence gene expression in S. flexneri. J Bacteriol 176:4187–4191. https://doi.org/10.4161/gmic.19325
Prunier A-L, Schuch R, Fernandez RE et al (2007) nadA and nadB of S. flexneri 5a are antivirulence loci responsible for the synthesis of quinolinate, a small molecule inhibitor of Shigella pathogenicity. Microbiology 153:2363–2372. https://doi.org/10.1099/mic.0.2007/006916-0
Puhar A, Tronchere H, Payrastre B et al (2013) A Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P. Immunity 39:1121–1131. https://doi.org/10.1016/j.immuni.2013.11.013
Pupo GM, Lan R, Reeves PR (2000) Multiple independent origins of Shigella clones of E. coli and convergent evolution of many of their characteristics. Proc Natl Acad Sci U S A 97:10567–10572
Qadri MH, Ai-Gamdi MA, Al-Harfi RA (1995) Asymptomatic salmonella, Shigella and intestinal parasites among primary school children in the eastern province. J Family Community Med 2:36–40
Ramos HC, Rumbo M, Sirard J-C (2004) Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol 12:509–517. https://doi.org/10.1016/j.tim.2004.09.002
Raqib R, Ekberg C, Sharkar P et al (2002) Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2. Infect Immun 70:3199–3207
Raqib R, Lindberg AA, Björk L et al (1995) Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor beta type I receptors at the local site during the acute phase of Shigella infection. Infect Immun 63:3079–3087
Raqib R, Mia SM, Qadri F et al (2000) Innate immune responses in children and adults with Shigellosis. Infect Immun 68:3620–3629
Romero S, Grompone G, Carayol N et al (2011) ATP-mediated Erk1/2 activation stimulates bacterial capture by filopodia, which precedes Shigella invasion of epithelial cells. Cell Host Microbe 9:508–519. https://doi.org/10.1016/j.chom.2011.05.005
Sadeghabadi AF, Ajami A, Fadaei R et al (2014) Widespread antibiotic resistance of diarrheagenic E. coli and Shigella species. J Res Med Sci 19:S51–S55
Sakellaris H, Hannink NK, Rajakumar K et al (2000) Curli loci of Shigella spp. Infect Immun 68:3780–3783
Salgado-Pabón W, Celli S, Arena ET et al (2013) Shigella impairs T lymphocyte dynamics in vivo. Proc Natl Acad Sci U S A 110:4458–4463. https://doi.org/10.1073/pnas.1300981110
Sansonetti PJ (2004) War and peace at mucosal surfaces. Nat Rev Immunol 4:953–964. https://doi.org/10.1038/nri1499
Sansonetti PJ, D’Hauteville H, Ecobichon C, Pourcel C (1983) Molecular comparison of virulence plasmids in Shigella and enteroinvasive E. coli. Ann Microbiol (Paris) 134A:295–318
Sansonetti PJ, Tran Van Nhieu G, Egile C (1999) Rupture of the intestinal epithelial barrier and mucosal invasion by S. flexneri. Clin Infect Dis 28:466–475. https://doi.org/10.1086/515150
Schroeder GN, Hilbi H (2008) Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 21:134–156. https://doi.org/10.1128/CMR.00032-07
Sellge G, Magalhaes JG, Konradt C et al (2010) Th17 cells are the dominant T cell subtype primed by S. flexneri mediating protective immunity. J Immunol 184:2076–2085. https://doi.org/10.4049/jimmunol.0900978
Senerovic L, Tsunoda SP, Goosmann C et al (2012) Spontaneous formation of IpaB ion channels in host cell membranes reveals how Shigella induces pyroptosis in macrophages. Cell Death Dis 3:e384. https://doi.org/10.1038/cddis.2012.124
Shim D-H, Suzuki T, Chang S-Y et al (2007) New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. J Immunol 178:2476–2482
Skoudy A, Mounier J, Aruffo A et al (2000) CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells. Cell Microbiol 2:19–33
Sperandio B, Fischer N, Joncquel Chevalier-Curt M et al (2013) Virulent S. flexneri affects secretion, expression, and glycosylation of gel-forming mucins in mucus-producing cells. Infect Immun 81:3632–3643. https://doi.org/10.1128/IAI.00551-13
Sperandio B, Regnault B, Guo J et al (2008) Virulent S. flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med 205:1121–1132. https://doi.org/10.1084/jem.20071698
Sudha PS, Devaraj H, Devaraj N (2001) Adherence of Shigella dysenteriae 1 to human colonic mucin. Curr Microbiol 42:381–387. https://doi.org/10.1007/s002840010234
Suzuki S, Mimuro H, Kim M et al (2014) Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages. Proc Natl Acad Sci U S A 111:E4254–E4263. https://doi.org/10.1073/pnas.1324021111
Tesh VL (2010) Induction of apoptosis by Shiga toxins. Future Microbiol 5:431–453. https://doi.org/10.2217/fmb.10.4
Tran Van Nhieu G, Ben-Ze’ev A, Sansonetti PJ (1997) Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J 16:2717–2729. https://doi.org/10.1093/emboj/16.10.2717
Tran Van Nhieu G, Caron E, Hall A, Sansonetti PJ (1999) IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J 18:3249–3262. https://doi.org/10.1093/emboj/18.12.3249
Tran van Nhieu G, Kai Liu B, Zhang J et al (2013) Actin-based confinement of calcium responses during Shigella invasion. Nat Commun 4:1567. https://doi.org/10.1038/ncomms2561
van den Broek JM, Roy SK, Khan WA et al (2005) Risk factors for mortality due to shigellosis: a case-control study among severely-malnourished children in Bangladesh. J Health Popul Nutr 23:259–265
van der Goot FG, Tran van Nhieu G, Allaoui A et al (2004) Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism. J Biol Chem 279:47792–47798
Watarai M, Funato S, Sasakawa C (1996) Interaction of Ipa proteins of S. flexneri with alpha5beta1 integrin promotes entry of the bacteria into mammalian cells. J Exp Med 183:991–999
Wei J, Goldberg MB, Burland V et al (2003) Complete genome sequence and comparative genomics of S. flexneri serotype 2a strain 2457T. Infect Immun 71:2775–2786
Weinrauch Y, Drujan D, Shapiro SD et al (2002) Neutrophil elastase targets virulence factors of enterobacteria. Nature 417:91–94. https://doi.org/10.1038/417091a
West NP, Sansonetti P, Mounier J et al (2005) Optimization of virulence functions through glucosylation of Shigella LPS. Science 307:1313–1317. https://doi.org/10.1126/science.1108472
Yang C, Li P, Zhang X et al (2016) Molecular characterization and analysis of high-level multidrug-resistance of S. flexneri serotype 4 s strains from China. Sci Rep 6:29124. https://doi.org/10.1038/srep29124
Yang F, Yang J, Zhang X et al (2005) Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res 33:6445–6458. https://doi.org/10.1093/nar/gki954
Yoshida S, Katayama E, Kuwae A et al (2002) Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. EMBO J 21:2923–2935. https://doi.org/10.1093/emboj/cdf319
Zhang Y-G, Sun J (2016) Study bacteria-host interactions using intestinal organoids. Methods Mol Biol. https://doi.org/10.1007/7651_2016_6
Zhang Z, Jin L, Champion G et al (2001) Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine. Infect Immun 69:3240–3247. https://doi.org/10.1128/IAI.69.5.3240-3247.2001
Zychlinsky A, Prevost MC, Sansonetti PJ (1992) S. flexneri induces apoptosis in infected macrophages. Nature 358:167–169. https://doi.org/10.1038/358167a0
Zychlinsky A, Thirumalai K, Arondel J et al (1996) In vivo apoptosis in S. flexneri infections. Infect Immun 64:5357–5365
Acknowledgements
The authors wish to thank Mark Anderson and Laurie Pinaud for critical reading of the chapter and proofreading.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Belotserkovsky, I., Sansonetti, P.J. (2018). Shigella and Enteroinvasive Escherichia Coli. In: Frankel, G., Ron, E. (eds) Escherichia coli, a Versatile Pathogen. Current Topics in Microbiology and Immunology, vol 416. Springer, Cham. https://doi.org/10.1007/82_2018_104
Download citation
DOI: https://doi.org/10.1007/82_2018_104
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99663-9
Online ISBN: 978-3-319-99664-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)